We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$356B
AUM Growth
+$14.1B
(+4.1%)
Cap. Flow
-$4.79B
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
3,385
New
54
Increased
1,101
Reduced
1,417
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SW
Smurfit Westrock
SW
|
+$622M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$269M |
| 3 |
Emerson Electric
EMR
|
+$268M |
| 4 |
ServiceNow
NOW
|
+$252M |
| 5 |
Analog Devices
ADI
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$542M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$499M |
| 3 |
Monster Beverage
MNST
|
+$326M |
| 4 |
NVIDIA
NVDA
|
+$316M |
| 5 |
McDonald's
MCD
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 11.08% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2301
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.36M | ﹤0.01% |
455,313
-600,749
| -57% | -$2.99M |
|
2302
Clear Channel Outdoor Holdings
CCO
$1.23B
| $2.36M | ﹤0.01% |
1,473,778
-66,961
| -4% | -$105K |
|
2303
iShares MSCI South Korea ETF
EWY
$24.1B
| $2.35M | ﹤0.01% |
36,798
-3,926
| -10% | -$254K |
|
2304
Globalstar
GSAT
$10.8B
| $2.35M | ﹤0.01% |
126,129
| – | – |
|
2305
Reynolds Consumer Products
REYN
$5.59B
| $2.34M | ﹤0.01% |
75,284
+10,223
| +16% | +$303K |
|
2306
Jack in the Box
JACK
$335M
| $2.33M | ﹤0.01% |
50,005
+1,357
| +3% | +$68.2K |
|
2307
Prudential
PUK
$35.2B
| $2.32M | ﹤0.01% |
125,113
-6,649
| -5% | -$116K |
|
2308
Alto Neuroscience
ANRO
$1.11B
| $2.3M | ﹤0.01% |
201,263
+163,564
| +434% | +$2M |
|
2309
Protolabs
PRLB
$2.13B
| $2.3M | ﹤0.01% |
78,382
-31,414
| -29% | -$958K |
|
2310
iShares MSCI EAFE ETF
EFA
$80.2B
| $2.3M | ﹤0.01% |
27,500
-432
| -2% | -$34.8K |
|
2311
ARS Pharmaceuticals
SPRY
$612M
| $2.29M | ﹤0.01% |
157,951
+3,517
| +2% | +$41.8K |
|
2312
SunCoke Energy
SXC
$797M
| $2.29M | ﹤0.01% |
263,340
-90,860
| -26% | -$841K |
|
|
DAWN
2313
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.28M | ﹤0.01% |
163,698
-27,208
| -14% | -$388K |
|
2314
Mativ Holdings
MATV
$711M
| $2.27M | ﹤0.01% |
133,773
| – | – |
|
2315
Trump Media & Technology Group
DJT
$2.83B
| $2.27M | ﹤0.01% |
140,962
+39,520
| +39% | +$958K |
|
2316
Comstock Resources
CRK
$3.94B
| $2.26M | ﹤0.01% |
203,122
+4,483
| +2% | +$46K |
|
2317
Bank First Corp
BFC
$1.7B
| $2.26M | ﹤0.01% |
24,912
| – | – |
|
2318
Arcturus Therapeutics
ARCT
$211M
| $2.26M | ﹤0.01% |
97,318
+7,675
| +9% | +$164K |
|
2319
NuScale Power
SMR
$4.03B
| $2.26M | ﹤0.01% |
194,957
| – | – |
|
|
RC
2320
Ready Capital
RC
$308M
| $2.25M | ﹤0.01% |
294,289
| – | – |
|
|
BRY
2321
DELISTED
Berry Corp
BRY
| $2.25M | ﹤0.01% |
436,912
+223,460
| +105% | +$1.36M |
|
2322
Enviri
NVRI
$620M
| $2.24M | ﹤0.01% |
216,736
-92,310
| -30% | -$972K |
|
2323
DXP Enterprises
DXPE
$2.98B
| $2.24M | ﹤0.01% |
41,900
-40,650
| -49% | -$2.04M |
|
2324
Sprinklr
CXM
$1.61B
| $2.23M | ﹤0.01% |
288,516
+29,349
| +11% | +$258K |
|
2325
Heritage Financial
HFWA
$1.21B
| $2.23M | ﹤0.01% |
102,381
+3,497
| +4% | +$74.6K |
|
Similar funds
VFT
Nuveen's Q3 2024 Portfolio in Review
As of Q3 2024, Nuveen held 3,385 positions worth $356B, up 4.1% from $342B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.1%. Nuveen opened 54 new positions and exited 52, leaving the 3,385-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q3 2024 buy was Smurfit Westrock: 13,669,531 shares worth $676M.
- Nuveen added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, an estimated $269M increase.
- Nuveen's biggest Q3 2024 reduction was Microsoft, cutting an estimated $542M.
- Nuveen fully exited iShares MSCI ACWI ETF in Q3 2024, selling an estimated $114M.
- Nuveen's ten largest holdings make up 30% of its $356B portfolio in Q3 2024.
- Nuveen opened 54 new positions and closed 52 in Q3 2024.
- Nuveen's portfolio value rose 4.1% quarter-over-quarter to $356B.
Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.